6-ketoprostaglandin-f1-alpha and Intestinal-Diseases

6-ketoprostaglandin-f1-alpha has been researched along with Intestinal-Diseases* in 3 studies

Other Studies

3 other study(ies) available for 6-ketoprostaglandin-f1-alpha and Intestinal-Diseases

ArticleYear
A windowless peek into the brain.
    Nature methods, 2014, Volume: 11, Issue:10

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprostone; Immunization; Immunization, Passive; Intestinal Diseases; Male; Stomach Ulcer; Thyroglobulin; Ulcer

2014
Procoagulant and prothrombotic responses of human endothelium to indomethacin and endotoxin in vitro. Relevance to non-steroidal anti-inflammatory drug enteropathy.
    Scandinavian journal of gastroenterology, 1995, Volume: 30, Issue:1

    In view of the association between non-steroidal anti-inflammatory drugs (NSAIDs) and microvascular injury in the intestine, this study investigated the procoagulant changes in cultured human umbilical vein endothelial cells (HUVEC) when exposed to indomethacin either alone or in the presence of bacterial lipopolysaccharide (LPS).. Confluent HUVEC cultures were cultured for 1, 6, 12, and 24 h in the presence of LPS (10 micrograms/ml) with or without indomethacin (1-100 microM). After incubation, supernatants were analysed for 6-keto-prostaglandin (PG) F1 alpha and PGE2 content, whereas cells were freeze-fractured and assayed in a one-stage clotting assay for the expression of procoagulant activity (PCA).. LPS induced a significant expression of PCA at 6, 12, and 24 h, with a significantly increased production of 6-keto-PGF1 alpha, whereas the increased PGE2 production was much less pronounced. Indomethacin alone induced a time-dependent PCA response; when coincubated with LPS the PCA response was greater than that produced by either indomethacin or LPS alone. Indomethacin totally abolished the synthesis of antithrombotic eicosanoids.. Indomethacin induces PCA in HUVEC and augments LPS-induced PCA, while it abolishes the antithrombotic prostanoid response in these cells. These observations may be relevant to the microvascular injury and thrombosis observed in NSAID enteropathy.

    Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Blood Coagulation Factors; Cells, Cultured; Dinoprostone; Eicosanoids; Endothelium, Vascular; Endotoxins; Humans; Indomethacin; Intestinal Diseases; Lipopolysaccharides; Thrombosis

1995
Effect of immunization with prostaglandin metabolites on gastrointestinal ulceration.
    The American journal of physiology, 1988, Volume: 255, Issue:6 Pt 1

    Active immunization of rabbits with a 6-ketoprostaglandin F1 alpha-thyroglobulin conjugate induced gastrointestinal ulceration, whereas active immunization of rabbits with 13,14-dihydro-15-keto prostaglandin E2-thyroglobulin conjugate or with thyroglobulin alone did not result in ulceration. Passive immunization of a separate group of rabbits with 6-ketoprostaglandin F1 alpha-hyperimmune plasma, obtained from actively 6-ketoprostaglandin F1 alpha-immunized donor rabbits that had ulcers, induced gastric ulceration within 9 days, whereas passive immunization of rabbits with control plasma, obtained from donor rabbits actively immunized with thyroglobulin alone, did not induce ulceration. Ulcerogenic donor plasma containing antibody to 6-ketoprostaglandin F1 alpha neutralized the inhibitory actions of prostacyclin on adenosine diphosphate-induced platelet aggregation, indicating that this antibody cross-reacted with prostacyclin. In contrast, plasma containing antibodies to 13,14-dihydro-15-ketoprostaglandin E2 cross-reacted only slightly with prostaglandin E2. Thus antibodies to inactive metabolites of prostaglandins induce ulceration only if these antibodies cross-react with an endogenous, "cytoprotective" prostaglandin.

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antibody Formation; Dinoprostone; Gastric Mucosa; Immunization; Immunization, Passive; Intestinal Diseases; Intestinal Mucosa; Male; Rabbits; Stomach Ulcer; Thyroglobulin; Ulcer

1988